aluates Reports

$ 0.0

Automative

Global Macular Edema and Macular Degeneration Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-10L9743

Global Macular Edema and Macular Degeneration Market Research Report 2022

BUY CHAPTERS

Global Macular Edema and Macular Degeneration Market Research Report 2025

Code: QYRE-Auto-10L9743

Report

February 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Novartis

GlaxoSmithKline PLC

Allergan plc

Regeneron Pharmaceuticals Inc

Alimera Sciences

Bausch Health Companies Inc.

Bayer

Kubota Pharmaceutical Holdings Co.

Macular Edema and Macular Degeneration Market Size

The global market for Macular Edema and Macular Degeneration was valued at US$ 9274 million in the year 2024 and is projected to reach a revised size of US$ 15080 million by 2031, growing at a CAGR of 7.3% during the forecast period.

Macular Edema and Macular Degeneration Market

Macular Edema and Macular Degeneration are two distinct eye conditions that affect the macula, a small but crucial part of the retina responsible for central vision and fine detail.

The market for macular edema treatment has been witnessing advancements in therapeutic options. Anti-VEGF (vascular endothelial growth factor) injections and corticosteroid implants are commonly used to manage macular edema, and new formulations and delivery methods were being explored to enhance treatment effectiveness and patient convenience.

This report aims to provide a comprehensive presentation of the global market for Macular Edema and Macular Degeneration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macular Edema and Macular Degeneration.

The Macular Edema and Macular Degeneration market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macular Edema and Macular Degeneration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Macular Edema and Macular Degeneration companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Macular Edema and Macular Degeneration Market Report

Report Metric	Details
Report Name	Macular Edema and Macular Degeneration Market
Accounted market size in year	US$ 9274 million
Forecasted market size in 2031	US$ 15080 million
CAGR	7.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Macular Edema Macular Degeneration
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Allergan, Regeneron Pharmaceuticals Inc, Alimera Sciences, Bausch Health Companies Inc., Kubota Pharmaceutical Holdings Co., Bayer AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macular Edema and Macular Degeneration company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Macular Edema and Macular Degeneration Market growing?

Ans: The Macular Edema and Macular Degeneration Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the Macular Edema and Macular Degeneration Market size in 2031?

Ans: The Macular Edema and Macular Degeneration Market size in 2031 will be US$ 15080 million.

Who are the main players in the Macular Edema and Macular Degeneration Market report?

Ans: The main players in the Macular Edema and Macular Degeneration Market are F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Allergan, Regeneron Pharmaceuticals Inc, Alimera Sciences, Bausch Health Companies Inc., Kubota Pharmaceutical Holdings Co., Bayer AG

What are the Application segmentation covered in the Macular Edema and Macular Degeneration Market report?

Ans: The Applications covered in the Macular Edema and Macular Degeneration Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Macular Edema and Macular Degeneration Market report?

Ans: The Types covered in the Macular Edema and Macular Degeneration Market report are Macular Edema, Macular Degeneration

Recommended Reports

Macular Degeneration

Retinal Disorders

Anti-VEGF Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Macular Edema and Macular Degeneration Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Macular Edema

1.2.3 Macular Degeneration

1.3 Market by Application

1.3.1 Global Macular Edema and Macular Degeneration Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Macular Edema and Macular Degeneration Market Perspective (2020-2031)

2.2 Global Macular Edema and Macular Degeneration Growth Trends by Region

2.2.1 Global Macular Edema and Macular Degeneration Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Macular Edema and Macular Degeneration Historic Market Size by Region (2020-2025)

2.2.3 Macular Edema and Macular Degeneration Forecasted Market Size by Region (2026-2031)

2.3 Macular Edema and Macular Degeneration Market Dynamics

2.3.1 Macular Edema and Macular Degeneration Industry Trends

2.3.2 Macular Edema and Macular Degeneration Market Drivers

2.3.3 Macular Edema and Macular Degeneration Market Challenges

2.3.4 Macular Edema and Macular Degeneration Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Macular Edema and Macular Degeneration Players by Revenue

3.1.1 Global Top Macular Edema and Macular Degeneration Players by Revenue (2020-2025)

3.1.2 Global Macular Edema and Macular Degeneration Revenue Market Share by Players (2020-2025)

3.2 Global Macular Edema and Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Macular Edema and Macular Degeneration Revenue

3.4 Global Macular Edema and Macular Degeneration Market Concentration Ratio

3.4.1 Global Macular Edema and Macular Degeneration Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Macular Edema and Macular Degeneration Revenue in 2024

3.5 Global Key Players of Macular Edema and Macular Degeneration Head office and Area Served

3.6 Global Key Players of Macular Edema and Macular Degeneration, Product and Application

3.7 Global Key Players of Macular Edema and Macular Degeneration, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Macular Edema and Macular Degeneration Breakdown Data by Type

4.1 Global Macular Edema and Macular Degeneration Historic Market Size by Type (2020-2025)

4.2 Global Macular Edema and Macular Degeneration Forecasted Market Size by Type (2026-2031)

5 Macular Edema and Macular Degeneration Breakdown Data by Application

5.1 Global Macular Edema and Macular Degeneration Historic Market Size by Application (2020-2025)

5.2 Global Macular Edema and Macular Degeneration Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Macular Edema and Macular Degeneration Market Size (2020-2031)

6.2 North America Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Macular Edema and Macular Degeneration Market Size by Country (2020-2025)

6.4 North America Macular Edema and Macular Degeneration Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Macular Edema and Macular Degeneration Market Size (2020-2031)

7.2 Europe Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Macular Edema and Macular Degeneration Market Size by Country (2020-2025)

7.4 Europe Macular Edema and Macular Degeneration Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Macular Edema and Macular Degeneration Market Size (2020-2031)

8.2 Asia-Pacific Macular Edema and Macular Degeneration Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2020-2025)

8.4 Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Macular Edema and Macular Degeneration Market Size (2020-2031)

9.2 Latin America Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Macular Edema and Macular Degeneration Market Size by Country (2020-2025)

9.4 Latin America Macular Edema and Macular Degeneration Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Macular Edema and Macular Degeneration Market Size (2020-2031)

10.2 Middle East & Africa Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2020-2025)

10.4 Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F. Hoffmann-La Roche Ltd

11.1.1 F. Hoffmann-La Roche Ltd Company Details

11.1.2 F. Hoffmann-La Roche Ltd Business Overview

11.1.3 F. Hoffmann-La Roche Ltd Macular Edema and Macular Degeneration Introduction

11.1.4 F. Hoffmann-La Roche Ltd Revenue in Macular Edema and Macular Degeneration Business (2020-2025)

11.1.5 F. Hoffmann-La Roche Ltd Recent Development

11.2 Novartis AG

11.2.1 Novartis AG Company Details

11.2.2 Novartis AG Business Overview

11.2.3 Novartis AG Macular Edema and Macular Degeneration Introduction

11.2.4 Novartis AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025)

11.2.5 Novartis AG Recent Development

11.3 GlaxoSmithKline plc

11.3.1 GlaxoSmithKline plc Company Details

11.3.2 GlaxoSmithKline plc Business Overview

11.3.3 GlaxoSmithKline plc Macular Edema and Macular Degeneration Introduction

11.3.4 GlaxoSmithKline plc Revenue in Macular Edema and Macular Degeneration Business (2020-2025)

11.3.5 GlaxoSmithKline plc Recent Development

11.4 Allergan

11.4.1 Allergan Company Details

11.4.2 Allergan Business Overview

11.4.3 Allergan Macular Edema and Macular Degeneration Introduction

11.4.4 Allergan Revenue in Macular Edema and Macular Degeneration Business (2020-2025)

11.4.5 Allergan Recent Development

11.5 Regeneron Pharmaceuticals Inc

11.5.1 Regeneron Pharmaceuticals Inc Company Details

11.5.2 Regeneron Pharmaceuticals Inc Business Overview

11.5.3 Regeneron Pharmaceuticals Inc Macular Edema and Macular Degeneration Introduction

11.5.4 Regeneron Pharmaceuticals Inc Revenue in Macular Edema and Macular Degeneration Business (2020-2025)

11.5.5 Regeneron Pharmaceuticals Inc Recent Development

11.6 Alimera Sciences

11.6.1 Alimera Sciences Company Details

11.6.2 Alimera Sciences Business Overview

11.6.3 Alimera Sciences Macular Edema and Macular Degeneration Introduction

11.6.4 Alimera Sciences Revenue in Macular Edema and Macular Degeneration Business (2020-2025)

11.6.5 Alimera Sciences Recent Development

11.7 Bausch Health Companies Inc.

11.7.1 Bausch Health Companies Inc. Company Details

11.7.2 Bausch Health Companies Inc. Business Overview

11.7.3 Bausch Health Companies Inc. Macular Edema and Macular Degeneration Introduction

11.7.4 Bausch Health Companies Inc. Revenue in Macular Edema and Macular Degeneration Business (2020-2025)

11.7.5 Bausch Health Companies Inc. Recent Development

11.8 Kubota Pharmaceutical Holdings Co.

11.8.1 Kubota Pharmaceutical Holdings Co. Company Details

11.8.2 Kubota Pharmaceutical Holdings Co. Business Overview

11.8.3 Kubota Pharmaceutical Holdings Co. Macular Edema and Macular Degeneration Introduction

11.8.4 Kubota Pharmaceutical Holdings Co. Revenue in Macular Edema and Macular Degeneration Business (2020-2025)

11.8.5 Kubota Pharmaceutical Holdings Co. Recent Development

11.9 Bayer AG

11.9.1 Bayer AG Company Details

11.9.2 Bayer AG Business Overview

11.9.3 Bayer AG Macular Edema and Macular Degeneration Introduction

11.9.4 Bayer AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025)

11.9.5 Bayer AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Novartis

GlaxoSmithKline PLC

Allergan plc

Regeneron Pharmaceuticals Inc

Alimera Sciences

Bausch Health Companies Inc.

Bayer

Kubota Pharmaceutical Holdings Co.

List of Tables

Table 1. Global Macular Edema and Macular Degeneration Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Macular Edema

Table 3. Key Players of Macular Degeneration

Table 4. Global Macular Edema and Macular Degeneration Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Macular Edema and Macular Degeneration Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Macular Edema and Macular Degeneration Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Macular Edema and Macular Degeneration Market Share by Region (2020-2025)

Table 8. Global Macular Edema and Macular Degeneration Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Macular Edema and Macular Degeneration Market Share by Region (2026-2031)

Table 10. Macular Edema and Macular Degeneration Market Trends

Table 11. Macular Edema and Macular Degeneration Market Drivers

Table 12. Macular Edema and Macular Degeneration Market Challenges

Table 13. Macular Edema and Macular Degeneration Market Restraints

Table 14. Global Macular Edema and Macular Degeneration Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Macular Edema and Macular Degeneration Market Share by Players (2020-2025)

Table 16. Global Top Macular Edema and Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema and Macular Degeneration as of 2024)

Table 17. Ranking of Global Top Macular Edema and Macular Degeneration Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Macular Edema and Macular Degeneration Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Macular Edema and Macular Degeneration, Headquarters and Area Served

Table 20. Global Key Players of Macular Edema and Macular Degeneration, Product and Application

Table 21. Global Key Players of Macular Edema and Macular Degeneration, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Macular Edema and Macular Degeneration Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Macular Edema and Macular Degeneration Revenue Market Share by Type (2020-2025)

Table 25. Global Macular Edema and Macular Degeneration Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Macular Edema and Macular Degeneration Revenue Market Share by Type (2026-2031)

Table 27. Global Macular Edema and Macular Degeneration Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Macular Edema and Macular Degeneration Revenue Market Share by Application (2020-2025)

Table 29. Global Macular Edema and Macular Degeneration Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Macular Edema and Macular Degeneration Revenue Market Share by Application (2026-2031)

Table 31. North America Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Macular Edema and Macular Degeneration Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)

Table 46. F. Hoffmann-La Roche Ltd Company Details

Table 47. F. Hoffmann-La Roche Ltd Business Overview

Table 48. F. Hoffmann-La Roche Ltd Macular Edema and Macular Degeneration Product

Table 49. F. Hoffmann-La Roche Ltd Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)

Table 50. F. Hoffmann-La Roche Ltd Recent Development

Table 51. Novartis AG Company Details

Table 52. Novartis AG Business Overview

Table 53. Novartis AG Macular Edema and Macular Degeneration Product

Table 54. Novartis AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)

Table 55. Novartis AG Recent Development

Table 56. GlaxoSmithKline plc Company Details

Table 57. GlaxoSmithKline plc Business Overview

Table 58. GlaxoSmithKline plc Macular Edema and Macular Degeneration Product

Table 59. GlaxoSmithKline plc Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)

Table 60. GlaxoSmithKline plc Recent Development

Table 61. Allergan Company Details

Table 62. Allergan Business Overview

Table 63. Allergan Macular Edema and Macular Degeneration Product

Table 64. Allergan Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)

Table 65. Allergan Recent Development

Table 66. Regeneron Pharmaceuticals Inc Company Details

Table 67. Regeneron Pharmaceuticals Inc Business Overview

Table 68. Regeneron Pharmaceuticals Inc Macular Edema and Macular Degeneration Product

Table 69. Regeneron Pharmaceuticals Inc Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)

Table 70. Regeneron Pharmaceuticals Inc Recent Development

Table 71. Alimera Sciences Company Details

Table 72. Alimera Sciences Business Overview

Table 73. Alimera Sciences Macular Edema and Macular Degeneration Product

Table 74. Alimera Sciences Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)

Table 75. Alimera Sciences Recent Development

Table 76. Bausch Health Companies Inc. Company Details

Table 77. Bausch Health Companies Inc. Business Overview

Table 78. Bausch Health Companies Inc. Macular Edema and Macular Degeneration Product

Table 79. Bausch Health Companies Inc. Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)

Table 80. Bausch Health Companies Inc. Recent Development

Table 81. Kubota Pharmaceutical Holdings Co. Company Details

Table 82. Kubota Pharmaceutical Holdings Co. Business Overview

Table 83. Kubota Pharmaceutical Holdings Co. Macular Edema and Macular Degeneration Product

Table 84. Kubota Pharmaceutical Holdings Co. Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)

Table 85. Kubota Pharmaceutical Holdings Co. Recent Development

Table 86. Bayer AG Company Details

Table 87. Bayer AG Business Overview

Table 88. Bayer AG Macular Edema and Macular Degeneration Product

Table 89. Bayer AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)

Table 90. Bayer AG Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Macular Edema and Macular Degeneration Picture

Figure 2. Global Macular Edema and Macular Degeneration Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Macular Edema and Macular Degeneration Market Share by Type: 2024 VS 2031

Figure 4. Macular Edema Features

Figure 5. Macular Degeneration Features

Figure 6. Global Macular Edema and Macular Degeneration Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Macular Edema and Macular Degeneration Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Macular Edema and Macular Degeneration Report Years Considered

Figure 12. Global Macular Edema and Macular Degeneration Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Macular Edema and Macular Degeneration Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Macular Edema and Macular Degeneration Market Share by Region: 2024 VS 2031

Figure 15. Global Macular Edema and Macular Degeneration Market Share by Players in 2024

Figure 16. Global Top Macular Edema and Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema and Macular Degeneration as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Macular Edema and Macular Degeneration Revenue in 2024

Figure 18. North America Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Macular Edema and Macular Degeneration Market Share by Country (2020-2031)

Figure 20. United States Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Macular Edema and Macular Degeneration Market Share by Country (2020-2031)

Figure 24. Germany Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Macular Edema and Macular Degeneration Market Share by Region (2020-2031)

Figure 32. China Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Macular Edema and Macular Degeneration Market Share by Country (2020-2031)

Figure 40. Mexico Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Macular Edema and Macular Degeneration Market Share by Country (2020-2031)

Figure 44. Turkey Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)

Figure 48. Novartis AG Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)

Figure 49. GlaxoSmithKline plc Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)

Figure 50. Allergan Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)

Figure 51. Regeneron Pharmaceuticals Inc Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)

Figure 52. Alimera Sciences Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)

Figure 53. Bausch Health Companies Inc. Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)

Figure 54. Kubota Pharmaceutical Holdings Co. Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)

Figure 55. Bayer AG Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Diabetic Macular Edema Treatment Market Research Report 2024

Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024

Global Macular Degeneration Treatment Market Research Report 2024

Global Ophthalmology for Age related Macular Degeneration Diseases Market Research Report 2024

Global Retinal Disorders Treatment Market Research Report 2024

Cystoid Edema Clinical Trials Market

Global Ophthalmology Disorders Drug Market Insights Forecast to 2030

Global Wet Macular Degeneration Market Research Report 2024

Global Non infectious Macular Edema Treatment Market Insights Forecast to 2030

Global Diabetic Macular Edema Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions